OR WAIT null SECS
March 13, 2024
The company is investing more than $2 million in its analytical testing services and adding suppository manufacturing capabilities.
February 15, 2024
The company’s Itasca, Ill., facility will offer chemistry, manufacturing, and controls analytical testing support.
February 03, 2024
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
February 02, 2024
Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.
Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.
December 02, 2023
By taking a strategic and evidence-based approach, companies can leverage the insights gained from stability studies to establish robust labeling.
November 27, 2023
MilliporeSigma has expanded its biosafety testing laboratories in Shanghai, China, with the completion of new lab space at its new €29 million (US$43 million) Biologics Testing Center.
November 02, 2023
The new centralized hub will provide advanced testing of nucleic acids, which is expected to simplify mRNA substance testing.
September 20, 2023
CN Bio and LifeNet Health LifeSciences have teamed up to provide direct access to a portfolio of highly characterized hepatic cells for the creation of advanced liver-on-a-chip assays.
September 13, 2023
Rentschler Biopharma’s ATMP business can now offer its full range of services for the clinical supply of AAV, including bioprocess and analytical development through to cGMP manufacturing at the Stevenage facility in the UK.